pocketful logo
Shivalik Rasayan Ltd logo

Shivalik Rasayan Ltd

NSE: SHIVALIK BSE: 539148

288.35

(-1.42%)

Tue, 03 Mar 2026, 09:18 pm

Shivalik Rasayan Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • Shivalik Rasayan is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
    • No need to calculate the sustainability of Shivalik Rasayan's dividends as it is not paying a notable one for India.
    • Shivalik Rasayan is not paying a notable dividend for India, therefore no need to check if the payments are stable.
    • Shivalik Rasayan's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
    • Shivalik Rasayan's dividend is below the markets top 25% of dividend payers in India (3.08%).

    future

    thumbs up icon

    Pros

    • Shivalik Rasayan's revenue growth is expected to exceed the India market average.
    thumbs up icon

    Cons

    • Shivalik Rasayan's revenue is expected to grow by 16.5% yearly, however this is not considered high growth (20% yearly).

    health

    thumbs up icon

    Pros

    • Shivalik Rasayan is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
    • Shivalik Rasayan is profitable, therefore cash runway is not a concern.
    • Shivalik Rasayan is profitable, therefore cash runway is not a concern.
    • Debt is covered by short term assets, assets are 20.4x debt.
    • Shivalik Rasayan's cash and other short term assets cover its long term commitments.
    • The level of debt compared to net worth has been reduced over the past 5 years (47% vs 3.9% today).
    • Shivalik Rasayan earns more interest than it pays, coverage of interest payments is not a concern.
    • Shivalik Rasayan's level of debt (3.9%) compared to net worth is satisfactory (less than 40%).
    thumbs up icon

    Cons

    • Operating cash flow is negative therefore debt is not well covered.
    • High level of physical assets or inventory.

    management

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • The average tenure for the Shivalik Rasayan board of directors is less than 3 years, this suggests a new board.
      • Vimal's remuneration is higher than average for companies of similar size in India.

      misc

      thumbs up icon

      Pros

        thumbs up icon

        Cons

        • Shivalik Rasayan is covered by less than 3 analysts.
        • Shivalik Rasayan has significant price volatility in the past 3 months.

        past

        thumbs up icon

        Pros

        • Shivalik Rasayan's 1-year earnings growth exceeds its 5-year average (75.5% vs 34.5%)
        • Shivalik Rasayan has delivered over 20% year on year earnings growth in the past 5 years.
        • Shivalik Rasayan's earnings growth has exceeded the IN Chemicals industry average in the past year (75.5% vs 9.1%).
        thumbs up icon

        Cons

        • Shivalik Rasayan used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
        • Shivalik Rasayan's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
        • Shivalik Rasayan has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).

        value

        thumbs up icon

        Pros

        • 539148 matched the Chemicals industry (2.2%) over the past year.
        • 539148 outperformed the Market in India which returned -14.5% over the past year.
        thumbs up icon

        Cons

        • Shivalik Rasayan's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
        • Shivalik Rasayan's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
        • Shivalik Rasayan is overvalued based on assets compared to the IN Chemicals industry average.
        • Shivalik Rasayan is overvalued based on earnings compared to the IN Chemicals industry average.
        • Shivalik Rasayan is overvalued based on earnings compared to the India market.
        • BSE:539148 is up 4.7% underperforming the Chemicals industry which returned 6.9% over the past month.
        • BSE:539148 is up 4.7% underperforming the market in India which returned 8% over the past month.

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Explore

        Calculatorsfooter arrow down icon
        Popular Calculatorsfooter arrow down icon
        Group Stocksfooter arrow down icon

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800